Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of combined oral contraceptives on brain and behavior (BECONTRA)
2024-519260-41-00Phase 4Authorised
- Sponsor
- University of Salzburg
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ethinyl estradiol + chlormadinone acetate and ethinylestradiol + levonorgestrel in None (2 arms), sponsored by University of Salzburg. Primary endpoints: Mood and self-perception, Cognition and 2 more. Planned start Dec 2024; status: authorised.
02
Drugs
ethinyl estradiol + chlormadinone acetateethinylestradiol + levonorgestrel
Beyond the preview
Go deeper on 2024-519260-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519260-41-00.